Bovine colostrum promotes growth and migration of the human keratinocyte HaCaT cell line

Growth Factors

Volumn 27, Issue 6, 2009, Pages 448-455

  Kovacs, Daniela ^a   Cardinali, Giorgia ^a   Aspite, Nicaela ^a   Picardo, Mauro ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

Bovine colostrum; Growth factors; Wound healing

Indexed keywords

ACTIN; BROMINE DERIVATIVE; BROXURIDINE; GENISTEIN; GROWTH PROMOTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEIN;

ARTICLE; BIOLOGICAL ACTIVITY; CELL GROWTH; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; COLOSTRUM; COW; CYTOSKELETON; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; KERATINOCYTE; MITOGENESIS; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TISSUE REPAIR; WOUND ASSESSMENT; WOUND HEALING;

ANIMALS; CATTLE; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; COLOSTRUM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PREGNANCY; RECEPTOR PROTEIN-TYROSINE KINASES; WOUND HEALING;

BOVINAE;

EID: 70450194703     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977190903211077     Document Type: Article

References (40)

1. An MJ, Cheon JH, Kim SW, Park JJ, Moon CM, Han SY, Kim ES, Kim TI, Kim WH. 2009. Bovine colostrum inhibits nuclear factor kappaB-mediated proinflammatory cytokine expression in intestinal epithelial cells. Nutr Res 29:275-280.
2. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. 2008. Growth factors and cytokines in wound healing. Wound Repair Regen 16:586-601.
3. Beer HD, Longaker MT, Werner S. 1997. Reduced expression of PDGF and PDGF receptors during impaired wound healing. J Invest Dermatol 109:132-138.
4. Brown GL, Nanney LB, Griffen J, Cramer AB, Yancey JM, Curtsinger LJ, III, Holtzin L, Schultz GS, Jurkiewicz MJ, Lynch JB. 1989. Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med 321:76-79.
5. Brown RL, Breeden MP, Greenhalgh DG. 1994. PDGF and TGFalpha act synergistically to improve wound healing in the genetically diabetic mouse. J Surg Res 56:562-570.
6. Cha D, O'Brien P, O'Toole EA, Woodley DT, Hudson LG. 1996. Enhanced modulation of keratinocyte motility by transforming growth factor-alpha (TGF-alpha) relative to epidermal growth factor (EGF). J Invest Dermatol 106:590-597.
7. Cooper DM, Yu E, Hennessey P, Ko F, Robson MC. 1994. Determination of endogenous cytokines in chronic wounds. Ann Surg 219:688-691.
8. Gope R. 2002. The effect of epidermal growth factor & plateletderived growth factors on wound healing process. Indian J Med Res 116:201-206.
9. Greenhalgh DG, Hummel RP, Albertson S, Breeden MP. 1993. Synergistic actions of platelet-derived growth factor and the insulin-like growth factors in vivo. Wound Repair Regen 1: 69-81.
10. Hennessey PJ, Black CT, Andrassy RJ. 1990. Epidermal growth factor and insulin act synergistically during diabetic healing. Arch Surg 125:926-929.
11. Hironaka T, Ohishi H, Masaki T. 1997. Identification and partial purification of a basic fibroblast growth factor-like growth factor derived from bovine colostrum. J Dairy Sci 80:488-495.
12. Huang C, Jacobson K, Schaller MD. 2004. MAP kinases and cell migration. J Cell Sci 117:4619-4628.
13. Hubbard SR, Miller WT. 2007. Receptor tyrosine kinases: mechanisms of activation and signaling. Curr Opin Cell Biol 19:117-123.
14. Jaschke E, Zabernigg A, Gattringer C. 1999. Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers. Int J Dermatol 38:380-386.
15. Khan Z, Macdonald C, Wicks AC, Holt MP, Floyd D, Ghosh S, Wright NA, Playford RJ. 2002. Use of 'nutriceutical', bovine colostrum, for the treatment of distal colitis: results from an initial study. Aliment Pharmacol Ther 16:1917-1922.
16. Klagsbrun M. 1980. Bovine colostrum supports the serum-free proliferation of epithelial cells but not of fibroblasts in long-term culture. J Cell Biol 84:808-814.
17. Lynch SE, Colvin RB, Antoniades HN. 1989. Growth factors in wound healing. J Clin Invest 84:640-646.
18. Mast BA, Schultz GS. 1996. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen 4:411-420.
19. Mattila PK, Lappalainen P. 2008. Filopodia: Molecular and cellular functions. Nat Rev Mol Cell Biol 9:446-454.
20. Pakkanen R, Aalto J. 1997. Growth factors and antimicrobial factors of bovine colostrum. Int Dairy J 285-297.
21. Pakkanen R, Kanttinen A, Satama L, Aalto J. 1992. Bovine colostrum fraction as a serum substitute for the cultivation of mouse hybridomas. Appl Microbiol Biotechnol 37:451-456.
22. Pastore S, Mascia F, Mariani V, Girolomoni G. 2008. The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol 128:1365-1374.
23. Pearson G, Robinson F, Beers Gibson T, Xu B-E, Karandikar M, Berman K, Cobb MH. 2001. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev 22:153-183.
24. Playford RJ, Floyd DN, Macdonald CE, Calnan DP, Adenekan RO, Johnson W, Goodlad RA, Marchbank T. 1999. Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut 44:653-658.
25. Playford R, Macdonald CE, Johnson WS. 2000. Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. Am J Clin Nutr 72:5-14.
26. Playford RJ, Macdonald CE, Calnan DP, Floyd DN, Podas T, Johnson W, Wicks A, Bashir O, Marchbank T. 2001. Coadministration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability. Clin Sci (Lond) 100: 627-633.
27. Purup S, Vestergaard M, Pedersen LO, Sejrsen K. 2007. Biological activity of bovine milk on proliferation of human intestinal cells. J Dairy Res 74:58-65.
28. Ramirez OT, Sureshkumar GK, Mutharasan R. 1990. Bovine colostrum or milk as a serum substitute for the cultivation of a mouse hybridoma. Biotechnol Bioeng 35:882-889.
29. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. 2003. Cell migration: integrating signals from front to back. Science 302:1704-1709.
30. Robson MC, Phillips LG, Thomason A, Robson LE, Pierce GF. 1992. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet 339:23-25.
31. Roux PP, Blenis J. 2004. ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68:320-344.
32. Santoro MM, Gaudino G. 2005. Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp Cell Res 304:274-286.
33. Schlessinger J. 2000. Cell signalling by receptor tyrosine kinase. Cell 103:211-225.
34. Singer AJ, Clark RA. 1999. Cutaneous wound healing. N Engl J Med 341:738-746.
35. Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH. 1999. Efficacy and safety of becaplermin (recombinabt human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: A combined analysis of four randomized studies. Wound Repair Regen 7:335-346.
36. Steimer KS, Packard R, HoldenD, KlagsburnM. 1981. The serumfree growth of cultured cells in bovine colostrum and in milk obtained later in the lactation period. J Cell Physiol 109: 223-234.
37. Sturani E, Zippel R, Toschi L, Morello L, Comoglio PM, Alberghina L. 1988. Kinetics and regulation of the tyrosine phosphorylation of epidermal growth factor receptor in intact A431 cells. Mol Cell Biol 8:1345-1351.
38. Takayama Y, Kitsunai K, Mizumachi K. 2001. Factors in bovine colostrum that enhance the migration of human fibroblasts in type I collagen gels. Bosci Biotechnol Biochem 65:2776-2779.
39. Torre C, Jeusette I, Serra M, Brazis P, Puigdemont A. 2006. Bovine colostrum increases proliferation of canine skin fibroblasts. J Nutr 136:2058S-2060S.
40. Werner S, Grose R. 2003. Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835-870.